Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Semaglutide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06967389
What this trial is testing

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

Who this might be right for
Obesity and OverweightObese AdolescentsWeight Management+2 more
John Bauer 50
Not applicableStudy completedNCT05230615
What this trial is testing

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 458
Early research (Phase 1)Study completedNCT04016974
What this trial is testing

A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese

Who this might be right for
Healthy VolunteersDiabetes Mellitus, Type 2
Novo Nordisk A/S 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT07090343
What this trial is testing

Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement

Who this might be right for
Aortic StenosisHeart Failure
Leiden University Medical Center 826
Not applicableLooking for participantsNCT07293325
What this trial is testing

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Who this might be right for
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine 66
Large-scale testing (Phase 3)Study completedNCT03574597
What this trial is testing

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

Who this might be right for
OverweightObesity
Novo Nordisk A/S 17,604
Large-scale testing (Phase 3)Active Not RecruitingNCT05726227
What this trial is testing

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Who this might be right for
Obesity
Novo Nordisk A/S 210
Early research (Phase 1)Study completedNCT04228354
What this trial is testing

A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide

Who this might be right for
Healthy VolunteersOverweightObesity
Novo Nordisk A/S 28
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Large-scale testing (Phase 3)Study completedNCT07271251
What this trial is testing

A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Novo Nordisk A/S 267
Early research (Phase 1)UnknownNCT06149260
What this trial is testing

Subcutaneous Semaglutide in Systemic Scleroderma

Who this might be right for
Scleroderma, SystemicFibrosisSemaglutide
Second Xiangya Hospital of Central South University 10
Post-approval studies (Phase 4)Looking for participantsNCT06852391
What this trial is testing

JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity

Who this might be right for
Obesity (Disorder)
McMaster University 74
Early research (Phase 1)Study completedNCT03707990
What this trial is testing

A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese

Who this might be right for
Obesity and Overweight
Novo Nordisk A/S 88
Not applicableActive Not RecruitingNCT07457424
What this trial is testing

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Who this might be right for
Metabolic DiseaseObesity & Overweight
University College Dublin 140
Testing effectiveness (Phase 2)Looking for participantsNCT05822609
What this trial is testing

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 1 Diabetes
University of Washington 60
Large-scale testing (Phase 3)Looking for participantsNCT05819138
What this trial is testing

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Who this might be right for
Diabetes Mellitus, Type 1
University of Colorado, Denver 60
Post-approval studies (Phase 4)Study completedNCT04263415
What this trial is testing

The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity

Who this might be right for
PCOSSemaglutideTaste, Altered+3 more
University Medical Centre Ljubljana 30
Early research (Phase 1)Ended earlyNCT04012255
What this trial is testing

A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Who this might be right for
OverweightObesity
Novo Nordisk A/S 29
Not applicableLooking for participantsNCT06856291
What this trial is testing

Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

Who this might be right for
Obesity and Obesity-related Medical ConditionsObesity and OverweightInsulin Sensitivity/Resistance+1 more
ETH Zurich 40
Not applicableStudy completedNCT06269120
What this trial is testing

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Who this might be right for
Type 2 Diabetes
Novo Nordisk A/S 243
Next Page